• Hikma accuses Amarin of suppressing generic versions of heart pill

    Source: NASDAQ US Markets / 22 Feb 2023 16:13:30   America/Chicago

    Generic drugmaker Hikma Pharmaceuticals USA Inc has sued Amarin Pharma Inc, accusing it of using illegal tactics to delay generic competition for its heart drug Vascepa. https://www.nasdaq.com/articles/hikma-accuses-amarin-of-suppressing-generic-versions-of-heart-pill
Share on,